EGFr, FGFr and PDGFr: Emerging Targets for Anticancer Drug Design

Journal of Cancer Research Updates
doi 10.6000/1929-2279.2016.05.03.3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Lifescience Global

Related search

Nuclear Receptors: Emerging Drug Targets for Parasitic Diseases

Journal of Clinical Investigation
Medicine
2017English

Anticancer Drug Targets: Growth Factors and Growth Factor Signaling

Journal of Clinical Investigation
Medicine
2000English

The Tuberculosis Drug Discovery and Development Pipeline and Emerging Drug Targets

Cold Spring Harbor perspectives in medicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

MicroRNAs and Other Non-Coding RNAs as Targets for Anticancer Drug Development

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2013English

Transcription Factor-Based Drug Design in Anticancer Drug Development

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
1997English

Emerging Drug Targets for Aβand Tau in Alzheimer's Disease: A Systematic Review

British Journal of Clinical Pharmacology
Pharmacology
2015English

Anticancer Drug Discovery — From Serendipity to Rational Design

2013English

Protein Tyrosine Kinase Panel as a Tool for Anticancer Drug Design

Acta Naturae
BiochemistryBiotechnologyMolecular MedicineMolecular Biology
2009English

Current and Emerging Targets in Immunotherapy for Osteosarcoma

Journal of Oncology
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy